Meeting
2018 ASCO Annual Meeting
Multiplex germline testing in selected melanomas presenting to oncology clinic.
Authors
Pauline Funchain
Cleveland Clinic, Cleveland, OH
Pauline Funchain , Brandie Heald , Jung Min Song , Emily Nizialek , Jessica Marquard , Michael J. McNamara , Ahmad A. Tarhini , Brian Gastman , Joshua Arbesman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Hereditary Genetics, and Epidemiology
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 36, 2018 (suppl; abstr 1588)
DOI
10.1200/JCO.2018.36.15_suppl.1588
Abstract #
1588
Poster Bd #
159
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Germline predisposition in oncologic and dermatologic melanoma cohorts.
First Author: Pauline Funchain
Poster
2019 ASCO Annual Meeting
Tumor sequencing with germline genetic testing: Identification of patients with hereditary cancer and precision treatment eligibility.
First Author: Scott T. Michalski
Poster
2022 ASCO Annual Meeting
Integrated germline and somatic cancer testing provides opportunity to identify cancer risk and resolve variant origins.
First Author: Kingshuk Das
Poster
2018 ASCO Annual Meeting
Non-BRCA hereditary gene mutations and breast cancer phenotype: An ISC-RAM Consortia study.
First Author: Banu Arun